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Summary A population based case-control study was conducted to determine whether risk of non-Hodgkin's lymphoma (NHL) in the
absence of HIV infection is related to the previous use of tobacco, alcohol or recreational drugs. A total of 378 residents of Los Angeles
County who were diagnosed with high- or intermediate-grade NHL were compared with individually age-, race- and sex-matched
neighbourhood control subjects with regard to history of use of tobacco products, alcohol and ten specific recreational drugs. Risk of NHL
among women decreased with increased consumption of alcoholic beverages (trend P= 0.03), with risk 50% lower among those consuming
five or more drinks per week than among non-drinkers. Cocaine, amphetamines, Quaaludes and lysergic acid diethylamide (LSD) were each
associated with a significantly increased risk of NHL in men with risk greater among those with more frequent use of these drugs.
Confounding factors could not be excluded in these findings. The use of multiple types of drugs was also associated with a significantly
increased risk of NHL in men (trend P = 0.005) with risk greatest among those using five or more types of drugs (odds ratio = 5.8, 95%
confidence limits = 1.2-28.4); among these drugs, cocaine use appeared to account for the elevated risk of NHL among men based on
multivariable analyses.
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Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of
tumours that account for approximately 3% of all cancers diag-
nosed in the United States (Boring et al, 1991). There is strong
evidence that the prevalence of these lymphomas has been
increasing for the last 30 years, with a more rapid rise observed
since the onset of the epidemic of acquired immune deficiency
syndrome (AIDS) (Ries et al, 1990). During the past 16 years, the
incidence rates of NHL have increased by more than 50% in the
United States, with a 4% increase per year for men and a 3%
increase per year for women (Ries et al, 1990).
Numerous studies have been conducted in an attempt to ascer-
tain the aetiology of NHL. Impairment of the immune system by
drugs, such as azathioprine and cyclosporin, orby infections, such
as human immunodeficiency virus (HIV), represent the most
firmly established settings in which NHL occurs with increased
incidence (Kinlen, 1992). Strong evidence suggests that the
Epstein-Barr virus (EBV) is causally associated with the NHL
occurrence under certain conditions of acquired or inherited
immune suppression (Mueller et al, 1992). Other immune aberra-
tions, such as autoimmune disorders including rheumatoid arthritis
(Isomaki et al, 1979; Kinlen, 1985) and Sjorgren's syndrome
(Kassam etal, 1978), have also been linked to greaterriskofNHL.
Neither immunosuppressive drugs nor infections, however, can
explain the recent increase in the incidence ofNHL in the general
population (Kinlen, 1992).
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To examine risk factors fordevelopment ofNHL, we conducted
apopulation-based case-control study in Los Angeles County. The
current work focuses on the use of tobacco, alcohol, and recre-
ational drugs as possible risk factors for the development ofNHL,
with results based upon the participants' histories of use of these
substances.
MATERIALS AND METHODS
Newly diagnosedpatients with NHL living in Los Angeles County
who were between the ages of 18 and 75 years at the time ofdiag-
nosis were identified by the Cancer Surveillance Program (CSP),
the population-based cancer registry for Los Angeles County,
using a rapid case reporting mechanism. All cases diagnosed
between April 1989 and November 1992, who were English- or
Spanish-speaking residents of Los Angeles County and were
diagnosed with high- or intermediate-grade tumours [classified
according to the Working Formulation (Rosenberg et al, 1982)]
were considered eligible for this study. Interviews were completed
with 525 patients. Two patients were mentally incapacitated and
not able to be interviewed. We were unable to interview 658
patients who had died, 44 who were too ill to be interviewed and
145 who refused to participate. Physicians denied permission to
contact an additional 57 patients.
Diagnostic biopsy materials were requested from all participants
in the study to allow for a uniform classification of disease and to
restrict eligibility to cases with a confirmed diagnosis of high- or
intermediate-grade NHL. All materials were reviewed and classi-
fiedby two experthaematopathologists. Twenty-seven interviewed
patients were determined to be ineligible for the study based upon
this review of pathology. The remaining 498 patients were
confirmed to have high- orintermediate-grade lymphomas. Biopsy
1532Alcohol, tobacco, anddrug use andriskofNHL 1533
Table 1 Relative odds of non-Hodgkin's lymphoma associated with current tobacco and alcohol use (based on 185 male matched pairs and 193 female
matched pairs)
Men Women
Drug use/ Odds 95% Trend Odds 95% Trend
frequency of use NHUcontrol ratio Cl P-value NHLlcontrol ratio Cl P-value
Cigarettes (per day)
Never smoked 70/79 1.00 Reference 113/102 1.00 Reference
Ever smoked 115/106 1.28 0.81-2.03 80/91 0.76 0.48-1.18
Former smoker 72/78 1.13 0.70-1.84 51/59 0.73 0.44-1.23
Current smoker 43/28 1.90 1.00-3.61 0.06 29/32 0.79 0.44-1.43 0.31
1-9 14/15 1.00 0.45-2.25 16/26 0.55 0.27-1.09
10-19 22/25 1.05 0.55-2.04 27/20 1.16 0.62-2.20
20+ 79/66 1.59 0.90-2.81 0.14 37/45 0.65 0.34-1.23 0.33
Total alcohol (drinks per week)
No current use 69/55 1.00 Reference 122/105 1.00 Reference
Any current use 116/130 0.68 0.43-1.08 71/88 0.63 0.40-1.00
0.1-4 37/46 0.61 0.34-1.12 45/47 0.74 0.43-1.27
5-11 29/48 0.45 0.24-0.84 13/21 0.51 0.24-1.06
12+ 50/36 1.09 0.60-1.98 0.82 13/20 0.50 0.23-1.09 0.03
Beer (12-oz cans per week)
No current use 93/98 1.00 Reference 160/158 1.00 Reference
Any current use 92/87 1.16 0.72-1.86 33/35 0.92 0.52-1.62
0.1-6 56/61 0.97 0.56-1.66 30/30 0.97 0.54-1.74
7+ 36/26 1.57 0.82-2.99 0.24 3/5 0.59 0.14-2.52 0.62
Wine (4-oz glasses per week)
No current use 120/108 1.00 Reference 140/126 1.00 Reference
Any current use 65/77 0.75 0.48-1.15 53/67 0.67 0.42-1.08
0.1-4 46/59 0.67 0.41-1.10 42/48 0.74 0.44-1.26
5+ 19/18 0.95 0.48-1.87 0.39 11/19 0.53 0.25-1.13 0.07
Spirits (1.5-oz shots per week)
No current use 114/103 1.00 Reference 154/140 1.00 Reference
Any current use 71/82 0.76 0.48-1.18 39/53 0.76 0.38-1.05
0.1-5 55/61 0.79 0.48-1.30 32/39 0.72 0.40-1.28
6+ 16/21 0.69 0.34-1.40 0.20 7/14 0.45 0.17-1.17 0.05
materials were unavailable for 29 cases (7.7%); among these
patients eligibility was determined based upon careful review of
pathology reports and results ofimmunophenotypic tests.
Although we had information on HIV status from patients or
their physicians at the time of interview, we obtained a blood
sample from each patient to confirm this status. HIV status was
determined by enzyme-linked immunosorbent assay, with confir-
matory Westem blotting, performed by standard methods. Of the
498 eligible NHL patients interviewed, a total of 378 were
confirmed to be HIV seronegative. The remaining 120 eligible
NHL patients were confirmed HIV seropositive and will be
considered in a separate analysis.
One control subject was individually matched to each inter-
viewed HIV-negative NHL patient on sex, age within 3 years,
race/ethnicity, language of interview (English or Spanish), and
neighbourhood ofresidence ofthe case at diagnosis. These neigh-
bourhood controls were identified by canvassing residences using
a predetermined algorithm through an obligatory sequence of
addresses beginning with a residence that had a specific geograph-
ical relationship to that of the case. The control identification
procedure continued until an eligible potential control had been
identified. For 31 patients (8.2%), no control was identified in the
neighbourhood; therefore a control was selected from a nearby
neighbourhood similar in socioeconomic status to the one initially
canvassed. For 263 cases, the first eligible control participated in
the study. In the remaining instances we had one (for 64 cases) or
more (for 51 cases) refusals before recruiting a control subject.
Before interview, an informed consent was obtained from each
subject. Study procedures were approved by the University of
Southem Califomia Research Committee in accord with assur-
ances approved by the US Department of Health and Human
Services. Personal interviews were conducted with each case and
control in a matched pair by nurse-epidemiologists. The interview
obtained information on the respondents' lifetime history of
medication usage, medical history (immunizations, chronic and
infectious diseases or other medical conditions), hospitalizations
and special treatments such as radiotherapy, blood transfusions,
and anaesthetic exposures, smoking and alcohol intake history, use
ofrecreational drugs, family medical history and occupational and
household exposure to a series of substances.
Foreach NHLpatient, exposure information was collected up to
the date that was 12 months before the date ofNHL diagnosis. The
same reference date was used for a patient's matched control.
Results presented here are based on the respondent's history of
alcohol use before the reference date, usual tobacco use and life-
time history ofrecreational drug use. For alcohol use, respondents
were asked about weekly use ofbeer, wine and spirits. Fortobacco
use, respondents were asked about the average number of ciga-
rettes smoked per day during the years they smoked. Respondents
were asked about lifetime exposure to marijuana, cocaine, heroin,
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Table 2 Relative odds of non-Hodgkin's lymphoma associated with lifetime drug use (based on 184 male
matched pairs)
Drug use/
frequency of use
Marijuana
No use
Any use
1-5 times
6-900 times
901+ times
Cocaine
No use
Any use
1-8 times
9+ times
Amphetamines
No use
Any use
1-15 times
16+ times
Barbiturates
No use
Any use
1-7 times
8+ times
LSD
No use
Any use
1-4 times
5+ times
Quaaludes
No use
Any use
1-2 times
3+ times
PCP
No use
Any use
1 time
2+ times
Mushrooms
No use
Any use
1 time
2+ times
Poppersa
No use
Any use
1-2 times
3+ times
Patients/ Odds 95% Trend
controls ratio Cl P-value
111/106
73/78
21/29
33/32
19/17
144/159
40/25
16/15
24/10
155/168
29/16
13/7
16/9
171/174
13/10
5/5
8/5
159/171
25/13
12/7
13/6
169/176
15/8
4/6
11/2
173/177
11/7
6/3
5/4
164/169
20/15
4/7
16/8
173/177
11/7
4/4
7/3
1.00
0.86
0.68
0.93
1.09
1.00
2.15
1.43
3.25
1.00
2.44
2.38
2.51
1.00
1.43
1.12
1.79
1.00
3.00
2.82
3.17
1.00
2.40
0.84
5.36
1.00
1.80
2.20
1.49
1.00
1.50
0.70
2.22
1.00
1.80
1.14
3.05
Reference
0.50-1.48
0.34-1.38
0.46-1.88
0.48-2.48
Reference
1.12-4.16
0.62-3.28
1.35-7.85
Reference
1.13-5.31
0.90-6.32
0.96-6.56
References
0.54-3.75
0.32-4.00
0.51-6.25
Reference
1.19-7.56
0.88-9.03
1.03-9.74
Reference
0.85-6.81
0.19-3.77
1.17-24.53
Reference
0.60-5.37
0.53-9.17
0.38-5.87
Reference
0.67-3.34
0.20-2.46
0.84-5.86
Reference
0.60-5.37
0.28-4.70
0.61-15.29
0.95
0.005
0.03
0.37
0.02
0.02
0.41
0.14
0.18
acombination of butyl nitrite, amyl nitrate, inhaled ethyl chloride and other sexual stimulants.
amphetamines, barbiturates, Quaaludes, lysergic acid diethyl-
amide (LSD), phenyl cyclohexyl piperidine (PCP), psychedelic
mushrooms and combined use of various types of poppers (butyl
nitrite, amyl nitrite, inhaled ethyl chloride and other sexual stimu-
lants). Information was obtained about the number of times these
substances were used, the month and year these substances were
first and last used, and the method of ingestion (e.g. smoking,
inhalation, injection). Because women rarely reported use of
recreational drugs in this study, only analyses for all drugs and
marijuana use and cocaine use were conducted.
STATISTICAL ANALYSES
Exposure categories were determined based upon the distribution
of use of each substance among the control subjects. The indi-
vidual pair matching was retained in the statistical analyses. The
odds ratios (OR) were estimated using conditional logistic regres-
sion methods (Breslow and Day, 1980). Ninety-five per cent confi-
dence intervals (CI) for the OR were estimated using the logarithm
of the OR and its standard error. A single degree of freedom test
was used to assess the significance oflineartrend across categories
of increasing exposure.
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Table 3 Relative odds of non-Hodgkin's lymphoma associated with number
of different types of recreational drugs used (based on 184 male matched
pairs)
Number of Odds 95% Trend
types useda NHUcontrol ratio CI P-value
0-1 149/160 1.00 Reference
2 11/14 1.02 (0.42-2.48)
3 10/5 2.50 (0.78-8.08)
4 4/2 3.31 (0.51-21.57)
5+ 10/3 5.76 (1.17-28.44) 0.005
aOnly drugs used three or more times are included in this score.
RESULTS
The majority of the patients participating in the study were non-
Latino whites (n = 253, 67%); 80 (21%) were Latinos; 25 (7%)
were African-Americans; and 20 (5%) were Asians. The mean age
of the male patients was 51.4 (standard deviation (s.d.) = 13.9),
whereas the mean age ofmale controls was 51.2 (s.d. = 14.3). The
mean age ofthe female patients was 52.1 (s.d. = 14.9), whereas the
mean age ofthe female controls was 51.8 (s.d. = 14.9).
The use ofcigarettes and alcohol among patients and controls is
presented in Table 1. Total intake ofalcohol was associated with a
significantly decreased risk of NHL in women (OR = 0.63; 95%
CI = 0.40-1.00), with risk lower among those with highest alcohol
consumption (trend P = 0.03). A statistically significant associa-
tion was not observed in men, although the OR estimate for any
use was similar to that ofwomen. The use ofwine andbeerin both
men and women was not associated with risk of NHL. Risk of
NHL decreased in women who consumed greater amounts of
spirits (trend P = 0.05). This association was also observed in men,
although results were not statistically significant. For both men
and women, the use of tobacco did not contribute to the risk of
high or intermediate grade NHL.
The results of matched univariate analyses of lifetime recre-
ational drug use in men is presented in Table 2. One male control
refused to answer any questions regarding recreational drug use;
therefore, this control and his matched case were excluded from
analyses of these exposures. Cases were significantly more likely
to have had a history of using cocaine (OR = 2.15, 95% CI =
1.12-4.16), amphetamines (OR = 2.44, 95% CI = 1.13-5.31) or
LSD (OR = 3.00, 95% CI = 1.19-7.56). With the exception of
marijuana (OR = 0.86, 95% CI = 0.50-1.48), risk was also
elevated for the other drugs, but the differences were not statisti-
cally significant. The use ofheroin was too infrequent to allow for
meaningful statistical analyses (data not shown). In women, no
significant associations were observed between use of all drugs
(OR = 0.77, 95% CI = 0.43-1.38), marijuana use (OR = 0.69, 95%
CI = 0.38-1.26) or cocaine use (OR = 1.44, 95% CI = 0.62-3.38).
The use of recreational drugs by women was too infrequent to
allow for any other meaningful statistical analyses. Table 2 also
presents data concerning dose-response relationships in men. A
statistically significant trend was observed with increasing use of
cocaine (P = 0.005), amphetamines (P = 0.03), Quaaludes (P =
0.02), and LSD (P = 0.02), although for amphetamines and LSD
the two categories ofuse resulted in similar odds ratios.
A stepwise multiple logistic regression analysis was performed
on the ten binomial (any use/no use) recreational drug variables.
Men who use one type of drug were more likely to use several
types ofdrugs. Thus, in a stepwise logistic regression model, only
the use of cocaine remained a significant predictor of NHL risk
(P = 0.02). Applying a drug summary score similar to that used by
Armenian et al (1996), the use of multiple types of drugs was
assessed for persons using a particular recreational drug at least
three times (Table 3). The use of a drug at least three times was
selected a priori to reflect that the use of a particular drug was
more likely to be habitual than experimental. Cases were signifi-
cantly more likely to have used five or more types ofdrugs at least
three times each (OR = 5.76, 95% CI = 1.17-28.44). A statistically
significant trend was also observed between NHL and greater
number ofdifferent types ofdrugs used (P =0.005). Note, consid-
ering any use of a drug in creating the summary variable (rather
than requiring use at least three times) produced similar risk esti-
mates (trend P = 0.01; 5 +drugsused vs 0 or 1, OR = 5.36, 95% CI
= 1.74-16.50). Users of cocaine were significantly more likely
than abstainers to use multiple types ofdrugs (P < 0.0001).
Matched univariate analyses were performed on use of recre-
ational drugs within the last 5 years. Only the use of cocaine was
significantly associated with an increased riskofNHL (OR =2.44,
95% CI = 1.13-5.31). Similarly, use of recreational drugs within
the last 10 years was also examined. Again, only use of cocaine
was significantly associated with an increased risk ofNHL (OR =
2.08, 95% CI = 1.07-4.03).
Analyses were also performed that included the case-control
pair in which the control refused to respond to the recreational
drug use questions. In these analyses, we assumed that the control
had used each ofthe drugs. Although the odds ratio estimates were
slightly attenuated in these analysis, all statistically significant
results remained significant.
DISCUSSION
The incidence of NHL has increased substantially in the United
States over the past 30 years (Devesa and Fears, 1990). Although
the onset ofthe AIDS epidemic and development ofAIDS-related
lymphomahas contributed tothis overallincrease, the incidence of
lymphoma had begun to increase substantially several decades
before this epidemic began. Further, the current increase in NHL
includes population groups who are not atriskfromHIV infection,
and specific types oflymphoma that are not associated with AIDS.
The precise reasons for the increase in NHL in the United
States, apart from AIDS, are not well understood. Recent data
have confirmed risk ofNHL in persons who have been exposed to
certain herbicides, such as 2,4-D and Agent Orange (Institute of
Medicine, 1993). Further, exposure to these agents for prolonged
periods, through contaminated work clothes has been associated
with chromosome breaks (Persson et al, 1993). A similar risk of
NHL among dogs exposed to 2,4-D has also been documented
(Hays et al, 1991). Although such exposure may explain an excess
of NHL among farmers or other selected exposed individuals, the
majority of cases of NHL still remain unexplained in terms of
potential aetiological orpathogenic factors.
The current population-based, case-control study has indicated
that use of certain recreational drugs may be associated with an
increased risk of NHL. Thus, past use of cocaine, amphetamines
and LSD were each associated with an increase in risk of NHL
among men on matchedunivariate analyses. Further, a statistically
significant trend was also observed with increasing amount of
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cocaine, amphetamines, Quaalude and LSD use. In a stepwise
logistic regression model, only the use of cocaine remained a
significant predictor for development of lymphoma, although the
use ofmultiple different types ofdrugs was also associated with an
increased risk in this model. When use ofrecreational drugs within
the last 5 years was examined, again, only cocaine remained a
significant risk factor for NHL. This was also seen when recre-
ational drug use within the last 10 years was considered.
History of alcohol and tobacco use were not associated with an
increased risk of NHL among men, nor was use of marijuana,
barbiturates, PCP, mushrooms or poppers. Of interest, higher
weekly consumption of alcohol in women was associated with a
significantly decreased risk of NHL. Because past research has
concluded that there are no statistically significant associations
between NHL and alcohol consumption (Franceschi et al, 1989;
Brown et al, 1992), this apparent association may be due to a
chance finding (a type I error) or it may be the result of
confounding.
The increased risk of NHL appears related to the recreational
use ofcertain types ofdrugs or to the use ofmultiple types ofthese
drugs. Only the use ofcocaine remains significant in both the step-
wise regression model and the analyses ofdrug use within the last
5 and 10 years. As cocaine users were more likely to use other
types ofdrugs than cocaine abstainers, the use ofcocaine was also
a main predictor in the drug summary score. It seems probable that
cocaine is the drug primarily responsible for this increased risk of
NHL, although the association may be the result of confounding
factors that are not understood at this time.
A potential limitation ofthis study is that information regarding
the use of alcohol, tobacco and recreational drugs is dependent
upon the recall ofthe subject. One could speculate that NHL cases
may tend to over-report the amount of substances used. The
absence of any positive association for tobacco and alcohol,
however, provides reassurance that over-reporting is not the sole
factor behind the associations found.
The precise mechanism of the development of NHL among
recreational drug users remains unknown. However, cocaine is
associated with lymphocyte activation, and may be associated with
chronic antigenic stimulation (Matsui et al, 1993). In the setting of
on-going proliferation, and stimulation of the immune system, as
well as by drug-induced aberrations ofnormal immunity, arandom
chromosomal error could occur. An error such as a translocation
could result in the activation of certain oncogenes or deletion of
tumour-suppressor genes, which might allow a selective growth
advantage to a particular clone of B lymphocytes leading eventu-
ally to B-NHL (Gaidano and Dalla-Favera, 1992). Such a mecha-
nism has been proposed for the AIDS-related lymphomas, in
which chronic B-cell stimulation and proliferation are induced by
HIV itself, as well as by the inflammatory cytokines (IL-6; IL-10)
that are released as a consequence of HIV infection (Nakajima et
al, 1989; Levine, 1992; Masood etal, 1994). In this setting ofpoly-
clonal B cell proliferation, an accidental translocation between
chromosome 8 and chromosome 14 has been associated with
dysregulation of c-myc, and the eventual development of small
non-cleaved lymphoma (Subar et al, 1988; Ballerini et al, 1992;
Nakamura et al, 1993). Other specific genetic errors have also
been described, leading to other pathological types ofAIDS-NHL
(Gaidano et al, 1994).
Although recreational drug use alone, and in particular, cocaine
use, will not explain the overall increase in NHL in the US, and
although we cannot rule out confounding as an explanation for our
finding, it is possible that use of these substances may explain
some of the increase in incidence. Of note, the recent, more rapid
increase in NHL incidence, which occurred even in areas with few
AIDS-related cases, coincides with the epidemic of recreational
drug use in the US (Devesa and Fears, 1992; Edlin et al, 1994).
Further study is indicated to determine the specific mechanisms
whereby recreational drugs might contribute to the risk of NHL,
and to determine other factors which might explain the significant
increase in NHL in the United States.
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